⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1765810 | 0.69 | — | — | |
| SCHEMBL20899788 | 0.67 | — | — | |
| SCHEMBL1765361 | 0.65 | — | — | |
| SCHEMBL6563825 | 0.64 | — | — | |
| SCHEMBL1655095 | 0.61 | — | — | |
| SCHEMBL5238 | 0.61 | — | — | |
| SCHEMBL1765686 | 0.60 | — | — | |
| SCHEMBL6564465 | 0.59 | — | — | |
| SCHEMBL6054 | 0.56 | — | — | |
| SCHEMBL626928 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 352 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025242747-A1 | MULTI -COMPONENT FORMULATIONS OF ORGANOMETALLIC REAGENTS | MERCK PATENT GMBH (DE) | 2025-11-27 | — | — | WO | claimed |
| JP-8143491-A | — | — | None | — | — | JP | disclosed |
| CN-116917280-B | Tetrahydronaphthalene compound, preparation method thereof and application thereof in medicine | 江苏恒瑞医药股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-4727647-A1 | GLYCOGEN SYNTHASE KINASE 3 INHIBITORS AND USES THEREOF | The Broad Institute Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260103465-A1 | GLYCOGEN SYNTHASE KINASE 3 INHIBITORS AND USES THEREOF | THE BROAD INSTITUTE, INC. (US) | 2026-04-16 | — | — | US | disclosed |
| US-12544747-B2 | Processes for producing fluorided solid oxides and uses thereof in metallocene-based catalyst systems | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-02-10 | — | — | US | disclosed |
| US-12516137-B2 | High porosity fluorided silica-coated alumina activator-supports and uses thereof in metallocene-based catalyst systems for olefin polymerization | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-01-06 | — | — | US | disclosed |
| WO-2025242747-A1 | MULTI -COMPONENT FORMULATIONS OF ORGANOMETALLIC REAGENTS | MERCK PATENT GMBH (DE) | 2025-11-27 | — | — | WO | disclosed |
| US-20250257155-A1 | HIGH POROSITY FLUORIDED SILICA-COATED ALUMINA ACTIVATOR-SUPPORTS AND USES THEREOF IN METALLOCENE-BASED CATALYST SYSTEMS FOR OLEFIN POLYMERIZATION | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2025-08-14 | — | — | US | disclosed |
| US-20250177966-A1 | Processes for Producing Fluorided Solid Oxides and Uses Thereof in Metallocene-Based Catalyst Systems | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2025-06-05 | — | — | US | disclosed |
| EP-0651643-A1 | 17-ALKYLKETONE STEROIDS USEFUL AS 5-$g(a)-REDUCTASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1995-05-10 | — | — | EP | disclosed |
| CN-1095382-A | The new A of cyanines family ring steroide | SMITHKLINE BEECHAM CORP (US) | 1994-11-23 | — | — | CN | disclosed |
| WO-1994000125-A1 | 17-ALKYLKETONE STEROIDS USEFUL AS 5-α-REDUCTASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1994-01-06 | — | — | WO | disclosed |
| CN-1071917-A | Quinazoline derivant as human immunodeficiency virus reversed transcriptive enzyme antagonist | MERCK & CO INC (US) | 1993-05-12 | — | — | CN | disclosed |
| EP-0530994-A1 | Quinazoline derivatives as inhibitors of HIV reverse transcriptase | MERCK & CO. INC. (US) | 1993-03-10 | — | — | EP | disclosed |
| WO-1993004047-A1 | QUINAZOLINE DERIVATIVES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE | MERCK & CO., INC. (US) | 1993-03-04 | — | — | WO | disclosed |
| EP-0245053-B1 | HETEROCYCLIC FUSED TRICYCLIC COMPOUNDS | ICI AMERICAS INC. (US) | 1992-11-25 | — | — | EP | disclosed |
| US-5118688-A | TETRAHYDROPYRIDOQUINOLONE DERIVATIVES USEFUL AS ANXIOLYTIC AGENTS | ICI AMERICAS INC. (US) | 1992-06-02 | — | — | US | disclosed |
| US-4975435-A | Certain 1H-pyrrold[3,4-b]quinolin-1-one-9-amino-2,3-dihydro derivatives useful for treating anxiety | ICI AMERICAS INC. (US) | 1990-12-04 | — | — | US | disclosed |
| EP-0245053-A1 | Heterocyclic fused tricyclic compounds | ICI AMERICAS INC. (US) | 1987-11-11 | — | — | EP | disclosed |